Aevice Well being has introduced that its flagship medical machine, a wearable stethoscope for respiratory well being monitoring, has been accredited by Singapore’s Well being Sciences Authority.
The AI-powered wearable stethoscope AeviceMD, which is worn on the chest, constantly detects and data irregular breath sounds, comparable to wheezing, and displays important indicators together with coronary heart charge and respiratory charge.
Based mostly on a press assertion, the monitoring machine system has been accredited to be used in individuals aged three and above and in each medical and residential settings.
WHY IT MATTERS
Singapore has one of many highest bronchial asthma and COPD prevalences on this planet. Bronchial asthma impacts round 5% of adults and 20% of youngsters within the nation whereas COPD is without doubt one of the 10 main illness killers.
With its distant well being monitoring know-how, Aevice Well being goals to assist cut back ED shows and readmissions amongst sufferers coping with these power respiratory ailments. By offering well being professionals with an summary of a affected person’s lung well being, AeviceMD helps the early detection of potential exacerbations.
In line with the corporate, it can use its HSA approval as a springboard to develop the attain of its know-how to populations with excessive circumstances of respiratory ailments.
“We’re excited to leverage Singapore’s strategic presence in Asia as a medical hub to convey this novel know-how into new markets the place there’s a excessive prevalence of respiratory ailments,” Aevice Well being CEO Adrian Ang shared.
THE LARGER TREND
The market approval comes two years since Aevice Well being first carried out a clinical trial of AeviceMD with the Nationwide College Well being System to analyze its use circumstances in paediatric sufferers with respiratory difficulties.
Except for Singapore, the machine has additionally been introduced in Japan utilizing the $2 million proceeds from its pre-Sequence A funding spherical in 2021.